![Brendan Hannah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brendan Hannah
Plus aucun poste en cours
Fortune : 56 097 $ au 30/09/2026
Profil
Mr. Brendan Hannah was previously employed as a COO, Chief Business & Compliance Officer by Quince Therapeutics, Inc., a Chief Operating Officer by Novosteo, Inc., a Chief Business Officer by Neuroptika, Inc., a Head-Corporate Development by Agenovir Corp., a Vice President-Operations & Strategy by Geom Therapeutics, Inc., and a Director-Business Development by Cidara Therapeutics, Inc. He received his undergraduate degree from The Colorado College and an MBA from Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IRULYA THERAPEUTICS INC. 0,02 % | 29/07/2026 | 1 809 ( 0,02 % ) | 56 097 $ | 30/09/2026 |
Anciens postes connus de Brendan Hannah
| Sociétés | Poste | Fin |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Directeur Financier/CFO | 08/10/2026 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Directeur des opérations | 01/05/2022 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Corporate Officer/Principal | 01/10/2021 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Corporate Officer/Principal | 01/03/2020 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Corporate Officer/Principal | 01/01/2018 |
Formation de Brendan Hannah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
